LGALS3 and COVID-19: Compared to healthy controls (13.57 [10.9-16.4] ng/mL), serum Gal-3 levels were higher in COVID-19 patients. However, Gal-3 levels were significantly lower in severe/critical disease group compared to healthy controls (13.52 [10.69-16.60] ng/mL; P=0.019) and compared to moderate disease group (11.65 [6.09-14.33] ng/mL; P=0.019).